As an innovative sublingual tablet, this product stands out for its effectiveness and ease of use. By harnessing the power of semaglutide, GetSimpli provides a natural approach to weight loss that ...

BioNxt Solutions Inc., a bioscience company specializing in advanced drug delivery systems, announces the development of a sublingual thin-film oral dissolvable film for Semaglutide, internally ...

Compounded semaglutide is an ill-defined public health crisis As a cardiologist, I’m seeing vulnerable patients seeking Wegovy and other GLP-1s turn to questionable yet convenient solutions online ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of patients and offering new hope for those with the life-threatening condition.

The sublingual semaglutide program will be available to eligible patients starting January 8 through Found’s comprehensive care platform. For more information about Found’s approach to ...

The semaglutide group achieved a weight loss of 10.5% at 72 weeks compared with 2% for adults receiving placebo (estimated difference, –8.5 percentage points; 95% CI, –9.6 to –7.4; P < .001).

Sublingual administration offers a potential alternative to both the approved injectable semaglutide (Ozempic and Wegovy) and the oral form (Rybelsus), providing a non-invasive route that allows ...

Semaglutide, a long-acting analogue of GLP-1, administered at a dose of 2.4 mg subcutaneously once weekly for 104 weeks, was found to reduce body weight by a mean of 15.2% among patients with ...

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation Apr. 28, 2025 8:00 AM ET Galmed Pharmaceuticals Ltd. (GLMD) ...